Transaction #12236 · Form 4 · 0001644975-25-000006
Mineralys Therapeutics, Inc. · Exercise / conversion · Common Stock
Mineralys Therapeutics, Inc. · Transacted November 21, 2025 · Filed November 24, 2025
What does this filing report?
An SEC Form 4 filing for Mineralys Therapeutics, Inc. records an exercise / conversion involving Common Stock on November 21, 2025. The reported quantity was 24,082. The filing date is November 24, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Mineralys Therapeutics, Inc.
- Company CIK
- 0001933414
- Security type
- Non-derivative
- Acquisition type
- Exercise / conversion · Code M
- Quantity acquired
- 24,082
- Reported price
- 0.54
- Reference value
- 13,004.28
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 655,387
- Ownership description
- Not reported
- SEC acceptance time
- Nov 24, 2025, 5:07 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Congleton Jon ↗
Chief Executive Officer · Director
CIK 0001644975
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- Due to a rounding error, the exercise price for this stock option was originally reported as $0.53 per share on the Reporting Person's Form 3 filed on February 9, 2023.
- F2
- The stock option vested with respect to 25% of the underlying shares on March 12, 2022 and the remaining shares in 36 substantially equal monthly installments thereafter.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.